Kovacs Shane William Charles

Track

Insider profile

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 22% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kovacs Shane William Charles's trades of Olema Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-16 2026-03-16
PrS Proposed sale
50,738
271.98
US$1,703,119 		50,738 271.98 US$1,703,119
2026-03-16 2026-03-16
PrS Proposed sale
87,638
404.19
US$2,130,478 		87,638 404.19 US$2,130,478
2026-03-11 2026-03-11
PrS Proposed sale
29,718
410.57
US$181,906 		29,718 410.57 US$181,906
2026-03-10 2026-03-10
PrS Proposed sale
53,206
17.00
US$904,566 		53,206 17.00 US$904,566
2026-03-09 2026-03-09
PrS Proposed sale
241,999
13.45
US$3,254,933 		241,999 13.45 US$3,254,933
2026-03-04 2026-03-04
PrS Proposed sale
20,000
24.43
US$488,654 		20,000 24.43 US$488,654
2026-02-27 2026-02-27
PrS Proposed sale
6,521
25.00
US$163,026 		6,521 25.00 US$163,026
2026-02-24 2026-02-24
PrS Proposed sale
20,000
25.00
US$500,002 		20,000 25.00 US$500,002
2026-02-23 2026-02-23
PrS Proposed sale
10,000
24.30
US$243,000 		10,000 24.30 US$243,000
2026-02-23 2026-02-23
PrS Proposed sale
20,000
24.00
US$480,007 		20,000 24.00 US$480,007
2026-02-12 2026-02-12
PrS Proposed sale
10,000
23.85
US$238,498 		10,000 23.85 US$238,498
2026-01-15 2026-01-15
PrS Proposed sale
100,000
28.73
US$2,873,215 		100,000 28.73 US$2,873,215
2026-01-15 2026-01-15
S Sale
100,000 -41.7%
28.73
US$2,873,000 		100,000 -41.7% 28.73 US$2,873,000
2026-01-15 2026-01-13
S Sale
3,822 -1.6%
28.01
US$107,054 		3,822 -1.6% 28.01 US$107,054
2026-01-13 2026-01-13
PrS Proposed sale
3,822
28.01
US$107,069 		3,822 28.01 US$107,069
2024-12-11 2024-12-11
PrS Proposed sale
18,356
8.68
US$159,345 		18,356 8.68 US$159,345
2024-12-11 2024-12-11
S Sale
406 -0.1%
9.39
US$3,812 		406 -0.1% 9.39 US$3,812
2024-12-11 2024-12-11
S Sale
17,950 -3.2%
8.66
US$155,447 		17,950 -3.2% 8.66 US$155,447
2024-12-11 2024-12-10
S Sale
16,803 -2.9%
9.37
US$157,444 		16,803 -2.9% 9.37 US$157,444
2024-12-10 2024-12-10
PrS Proposed sale
16,803
9.37
US$157,426 		16,803 9.37 US$157,426
2023-11-22 2023-11-22
PrS Proposed sale
9,145
13.89
US$127,004 		9,145 13.89 US$127,004
2023-11-22 2023-11-22
S Sale
9,145 -2.1%
13.89
US$127,024 		9,145 -2.1% 13.89 US$127,024
2023-11-22 2023-11-21
S Sale
700 -0.2%
15.27
US$10,689 		700 -0.2% 15.27 US$10,689
2023-11-22 2023-11-21
S Sale
8,897 -2.0%
14.83
US$131,943 		8,897 -2.0% 14.83 US$131,943
2023-11-21 2023-11-21
PrS Proposed sale
9,597
14.87
US$142,661 		9,597 14.87 US$142,661
2023-04-07 2023-04-06
PP Planned purchase
10,000
0.00
US$0 		10,000 0.00 US$0
2022-09-06 2022-09-02
PP Planned purchase
20,000
0.00
US$0 		20,000 0.00 US$0